Celldex Therapeutics | CLDX - Vermögenswerte





Vermögenswerte Veränderung Datum
AbbVie USD 147.68B 12.57B 2026-09
Agenus USD 172.69M 13.76M 2026-06
Amgen USD 96.05B 409M 2026-09
Bristol-Myers Squibb USD 88.77B 1.14B 2026-09
Celldex Therapeutics USD 721.53M 60.82M 2026-09
Glaxosmithkline GBP 71.7B 8.83B 2026-09
Nektar Therapeutics USD 763.27M 482.86M 2026-03
Northwest Biotherapeutics USD 80.05M 49.44M 2026-03
Pfizer USD 204.54B 3.41B 2026-09
Rigel Pharmaceuticals USD 242.53M 35.8M 2025-09
Roche Holding CHF 98.2B 2.5B 2026-06